Zerenia Clinic UK

Blog

April 2022 Medical Cannabis in Germany and the UK 5 years of medical cannabis on prescription – the most important questions and answers Since the so-called “Cannabis Act” came into force on March 10, 2017, doctors have been able to prescribe medical cannabis to patients with serious illnesses and in the absence of alternative therapies.

March 2022 Khiron totals 16 medical cannabis clinics across the glob Khiron Life Sciences Corp. now has a total of 16 medical cannabis clinics across the globe with the opening of a new location in Peru. Khiron’s latest addition of Zerenia™ has opened in Lima, Peru. The company has partnered with the specialised pain clinic,

The CBD-ilemma

March 2022 The CBD-ilemma The approval of epidyolex for the treatment of refractory pediatric epilepsy is providing an increasing body of evidence on the therapeutic potential of cannabidiol (CBD), which had already showed promise to address other clinical conditions such as anxiety, psychotic symptoms, or substance use disorders. Owing to this therapeutical promise and fueled

February 2022 What are cannabis chemovars and chemotypes? The categorisation and nomenclature of cannabis is more complex than you might think – and also more important. The standard categorization in recent decades, strains, is on its way out. It is being replaced by more accurate and flexible terms, such as chemovars and chemotypes. At Khiron,

February 2022 First Khiron specialist medical cannabis clinic opens in Europe Khiron Life Sciences Corp. is one of the world’s leading medical cannabis companies. Not only in Latin American countries such as Colombia, Peru, Brazil and now soon Mexico, Khiron has long been strongly represented in the market for medical cannabis, but also in Europe,